|When: 8:30 am – 4:30 pm, Saturday, November 12, 2011
Where: Institute of Americas, UCSD (please clickherefor map)Organizer:Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA)
Link to SABPA report on this successful event.
Clickherefor slides of Pharmaceutical Innovations panel discussion .
Clickherefor slides of Bio therapeutics panel discussion.
Clickherefor slides from Hefner on Biotherapeutics and IP.
$20 for early birds by Nov 5; $30 by Nov 8; $50 for onsite registration. $10 off for students and postdocs. Fees include program brochure, continental breakfast, coffee, lunch and onsite reception.Online registration closes on Nov 9.
8:30 am Breakfast and Registration
9:00 am Opening Remarks
Peter Zhu, President, SABPA; Senior Scientist, Pfizer
Yung-Chih Wang, Ph.D., MBA, Chair, Pacific Alliance Committee, SABPA; VP, Corporate Development, China, HUYA Bioscience International
9:10 am BioAccelerating Drug Development
Jay Short, Ph.D., Chairman & CEO, BioAtla
9:30 am (Presentation title TBD)
Wolfgang Noe, Ph.D., Senior Consultant, BioProcess Technology Consultants, Inc.
10:00 am Developing an International IP Strategy that Includes Biotherapeutic Technologies
Jerry Hefner, Ph.D., J.D., Partner, Knobbe Martens Olson & Bear LLP
10:30 am Coffee Break
10:50 amPanel Discussion: Biotherapeutics
Session Leader:Hui Li, Chairman of the Board, SABPA; Director of Business of Development, PPD
Kevin Chen, VP, China GM and Co-founder, Innovent Biologics, Inc.
Xuehai Tan, CEO, HD Biosciences
Xiaodong Yang, President and CEO, Apexigen
12:00 am Lunch
1:20 pm Opening of Afternoon Sessions
Stephanie Shi, Ph.D., Co-Chair, Pacific Alliance, SABPA; Integrated Sourcing Lead, External Research Solutions, Pfizer
1:30 pm Melissa M. Fitzgerald,Ph.D.,Head, Strategic Research Partnerships-San Diego, External R&D Innovation, Pfizer
2:00 pmFrom Generics to Innovative Medicine in China Strategies, Challenges, and Outlook
Peng Wang, Ph.D., CSO, SimcerePharmaceutical Group
2:30 pm Coffee Break
2:50 pmPanel Discussion: Pharmaceutical Innovations
Session Leader:Sergio Gurrieri, Ph.D., MBA, Investor, Tech Coast Angels
Chunlin Chen, Ph.D., CEO, Medicilon
Tina Huang, General Manager, Preclinical Services, Pharmaron
Larry Wang, President, Genscript
Ming Guo, Ph.D., Co-Founder & COO, Ascentage Pharma
Xifu Liu, Ph.D., President, Zensun USA, Inc.
4:20 pm Closing Remarks
Mingzhu Zhang, Ph.D., Executive VP, SABPA; VP of Business Development, Shanghai Medicilon
4:30 pmOnsite Reception